Location History:
- Buffalo, NY (US) (2015 - 2016)
- Eggertsville, NY (US) (2002 - 2019)
- Amherst, NJ (US) (2020 - 2023)
- Amherst, NY (US) (2008 - 2024)
Company Filing History:
7 out of 9 
5 out of 6 
5 out of 5 Years Active: 2002-2025
Title: **Jerome J. Schentag: Innovator in Therapeutic Nanoparticle Technology**
Introduction
Jerome J. Schentag, based in Amherst, NY, is a notable inventor with a remarkable portfolio of 22 patents. His work primarily focuses on innovative methods for drug delivery and treatment technologies, particularly involving cholestosome vesicles.
Latest Patents
Among his latest inventions, Schentag has developed methods of treatment using cholestosome vesicles for the incorporation of molecules into chylomicrons. This invention features a unique cargo-loaded cholesteryl ester nanoparticle, referred to as 'cholestosome.' This nanoparticle comprises a hollow compartment made of non-ionic cholesteryl ester and encapsulated active molecules that are unable to traverse enterocyte membranes without being incorporated into the cholestosome. The neutral surface of the cholestosome allows it to pass into enterocytes, leveraging the pathways used by orally absorbed nutrient lipids to reach the Golgi apparatus. This innovative technology aims to deposit active molecules within patient cells effectively, facilitating therapeutic or diagnostic applications for various medical conditions.
Career Highlights
Throughout his career, Jerome Schentag has contributed significantly to the field of pharmaceutical sciences, with a focus on enhancing drug delivery mechanisms. His innovative approaches have led to advancements that are crucial for the effective treatment and diagnosis of patients.
Collaborations
Jerome has collaborated with esteemed professionals in his field, including Joseph M. Fayad and Mohan Kabadi. These collaborations have likely enhanced his research output and the successful implementation of his innovative ideas. He has also worked with companies such as Therasyn Sensors, Inc. and Volant Holdings GmbH, contributing to his reputation as an experienced inventor in the biotechnology sector.
Conclusion
Jerome J. Schentag’s contributions to the field of nanotechnology and drug delivery through his patents and collaborations underline his role as a leading innovator. With 22 patents to his name, his ongoing research and development efforts continue to pave the way for advancements in therapeutic treatment methodologies, showcasing his commitment to improving patient care through innovative solutions.